SVETLANA ZOLOTUKHINA: Open Payments
NPI 1073897096 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 10 payments from 8 companies in 2025. Trend: 2023 $20 · 2024 $1,424 · 2025 $525
Food & beverage: $410Education: $95Travel & lodging: $20
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 1 | $123 |
| E.R. Squibb & Sons, L.L.C. | 1 | $103 |
| Lilly USA, LLC | 1 | $95 |
| Janssen Biotech, Inc. | 3 | $80 |
| SOBI, INC | 1 | $43 |
| Gilead Sciences, Inc. | 1 | $34 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $27 |
| PFIZER INC. | 1 | $20 |
Products named: Enhertu, OPDIVO, TECVAYLI, Vonjo, Trodelvy, PYLARIFY, TALVEY, IBRANCE.
Industry payments across TX — which companies pay providers there.
